[
    [
        {
            "time": "",
            "orginal_text": "医药生物行业：去伪存真",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "去伪存真"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药生物行业：去伪存真",
            "scores": {
                "News_content": "医药生物行业：去伪存真",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业周报：板块回调 关注估值切换带来低估值板块投资机遇",
            "features": {
                "keywords": [
                    "医药",
                    "板块回调",
                    "估值切换",
                    "低估值",
                    "投资机遇"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "医药行业周报：板块回调 关注估值切换带来低估值板块投资机遇",
            "scores": {
                "News_content": "医药行业周报：板块回调 关注估值切换带来低估值板块投资机遇",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业周报：国产创新药频繁授权海外 继续重点推荐创新药产业链",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "国产创新药",
                    "授权海外",
                    "创新药产业链"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药生物行业周报：国产创新药频繁授权海外 继续重点推荐创新药产业链",
            "scores": {
                "News_content": "医药生物行业周报：国产创新药频繁授权海外 继续重点推荐创新药产业链",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业每周医览药闻：2020年医药中报业绩总结：后疫情时代 关注需求复苏下蕴含的全球市场机会",
            "features": {
                "keywords": [
                    "医药",
                    "中报业绩",
                    "后疫情时代",
                    "需求复苏",
                    "全球市场机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药行业每周医览药闻：2020年医药中报业绩总结：后疫情时代 关注需求复苏下蕴含的全球市场机会",
            "scores": {
                "News_content": "医药行业每周医览药闻：2020年医药中报业绩总结：后疫情时代 关注需求复苏下蕴含的全球市场机会",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]